Bega Cheese Limited Overview
Bega Group is Australia's largest Australian-owned branded food and dairy company and one of the country's three largest milk processors. It received 1.43 billion litres of milk in FY2026.
It is a vertically integrated producer with two segments:
Branded consumer foods and beverages: (A$3.22bn of revenue, 85% of the group). Brands include Vegemite, Bega Peanut Butter, Dairy Farmers, Farmers Union, Dare, Big M, Pura, Yoplait (licensed), Daily Juice and Zooper Dooper.
Bulk Nutritionals and Ingredients: (A$552m). This covers milk protein concentrate, lactoferrin, infant-nutrition bases, cream cheese and dairy commodities.
The company holds #1 positions in milk-based beverages (43% share), spreads (26%) and water ice (92%), and #2 positions in yoghurt, fresh white milk and chilled juice.
Since 2017 it has moved from a commodity-exposed cheese co-operative to a brand-led FMCG business. The pivot was built on two acquisitions: Mondelez's grocery portfolio (2017) and Lion Dairy & Drinks (2021). It is now executing a footprint-simplification and protein-led innovation agenda under its "S31" plan, which targets normalised EBITDA above A$310m by FY2031.
Company's own description
The FY2026 Annual Report describes Bega Group as an integrated producer of branded packaged foods and beverages, nutritionals and ingredients used daily by millions of people. It operates two business types:
-
Branded: consumer and foodservice products sold through grocery, route, foodservice, and petrol and convenience channels.
-
Bulk Nutritionals and Ingredients: nutritional powders and dairy ingredients sold primarily to food manufacturers.
The stated vision is "to become the Great Australian Food Company". The purpose is "creating great food for a better future".
The company says its "right to win" rests on three pillars:
-
Category and brand focus, with five "power brands" holding #1 or #2 positions.
-
Low-cost Australian production with scale in key categories and accelerating automation.
-
Maximising value from procured materials, through bulk-to-branded integration, nutritional growth and a growing share of the Australian milk pool. (FY2026 Results Presentation, slide 8)
Business model and revenue model
| Revenue stream | Nature | FY2026 indicative scale |
|---|---|---|
| Branded retail (grocery) | Packaged consumer goods sold to Coles, Woolworths, Aldi, Metcash/IGA and independents | Majority of Branded revenue of A$3,222.6m |
| Branded route trade, petrol and convenience, foodservice | Direct-store-delivery chilled network; QSR, café and hospitality supply | Not separately disclosed; foodservice described as growing "above market" |
| Branded international | Bega cream cheese, cheese slices, yoghurt and Vegemite exported to SE Asia, North Asia and the Middle East | About 9% of Branded revenue (about A$290m derived) |
| Bulk Nutritionals and Ingredients | B2B: MPC, lactoferrin, infant formula bases, cream cheese, butter, milk powders; toll manufacturing | A$552.0m external; 58% international |
| Inter-segment supply (eliminated) | Bulk dairy solids supplied into Branded products | Not disclosed; strategically important |
| Brand licence income | Trademark licence for Bega-branded natural and processed cheddar and butter, historically licensed to Fonterra's Australian business (now Lactalis-owned) | — |
Bega's revenue is almost entirely product revenue. There is no meaningful service, subscription or licensing revenue reported as a separate line.
Value-chain position
Bega spans the chain from farm-gate milk procurement, buying directly from dairy farmers, through primary processing (milk separation, drying, cheese making), secondary manufacturing (yoghurt, milk-based beverages, spreads, juice, processed cheese) and chilled national distribution. It runs one of Australia's largest chilled food distribution networks, with about 29,000 customers and the MyBega B2B portal rolled out to more than 20,000 customers.
It has deliberately exited several non-core primary-processing steps:
-
Juice primary processing at Leeton (FY2025)
-
Primary peanut processing at Kingaroy and Tolga (FY2026)
In each case it replaced in-house processing with long-term supply agreements.
Customers and end-markets
| Customer type | End-market | Notes |
|---|---|---|
| Major grocery retailers | Australian packaged food and dairy | 97% of Australian households buy a Bega-branded product (Circana, MAT to June 2025) |
| Route, convenience and foodservice | Out-of-home dairy beverages, milk for cafés | Sensitive to foot traffic; foodservice outperformed in FY2025–FY2026 |
| International distributors (40+ countries) | Imported cheese and yoghurt in SE Asia, North Asia, Middle East | 92% of international revenue comes from these three regions |
| Food and nutrition manufacturers | Infant formula, sports and medical nutrition, high-protein beverages | MPC and lactoferrin demand linked to the global protein trend |
| Commodity buyers | Global dairy commodity markets | Exposure deliberately reduced post-FY2023 |
Independent characterisation
Bega is best understood as a mid-margin Australian branded staples business attached to a counter-cyclical-to-procyclical dairy ingredients engine.
The Branded segment earns about 6.8% EBITDA margins. That is low for global FMCG, but typical for chilled dairy, where distribution intensity and retailer concentration compress margins. The Bulk segment is volatile: it swung from an A$18.2m EBITDA loss (FY2024) to A$53.2m profit (FY2026). Its earnings depend on the spread between the Australian farm-gate milk price and global commodity returns.
The investment case since 2023 has been margin and returns repair rather than top-line growth:
-
ROFE rose from 3.7% in FY2023 to 10.0% in FY2026.
-
Normalised EPS rose from 9.4c to 22.6c.
The repair came through site closures, automation and mix shift to protein and "better for you" products. The strategic question for the next five years is whether Bega can convert this repaired platform into sustained double-digit EPS growth while preserving dry powder for transformational M&A. It lost the Fonterra Mainland contest to Lactalis in 2025.
Strategy
Strategic lineage
| Plan | Horizon | Headline targets | Status |
|---|---|---|---|
| S28 (launched with FY2023 results, August 2023) | FY2023–FY2028 | Normalised EBITDA A$250m+; ROFE 10%+ | ROFE target hit in FY2026, two years early. EBITDA tracking ahead; the FY2028 target was upgraded at the 2026 Investor Day. |
| S31 (unveiled at Investor Day, Morwell, late April 2026) | To FY2031 | Normalised EBITDA A$310m+; revenue A$4.3–4.7bn; EPS 37–39c; double-digit ROFE; 40% CO₂ reduction by 2030; safety targets | Year 1 (FY2026) "on track" |
S31 framework: "Simplify & Focus for Growth"
Source: FY2026 Annual Report pp.15–18; Results Presentation slide 11.
Objective 1: simplify, scale and enhance the business to reinforce competitive position.
Grow core brands and categories: Evolve products to meet changing consumer needs (protein, gut health, weight wellness), with go-to-market excellence across brand, product, price, pack and promotion.
Streamline our sites: Expand capability and capacity in growth categories, and optimise the footprint through scale and automation.
Secure solids: Grow and diversify milk-solids supply, including overseas solids where appropriate, and invest in value-add ingredients capability.
Objective 2: win in the markets where we choose to compete.
Win on the street: Grow foodservice, convenience and independent grocery, and expand availability while optimising logistics cost.
Accelerate international: Build scale through stronger, unified brands in Asia and the Middle East, and establish in-market supply chains, including in-market sourcing.
Enablers: safety; quality; people and capability; AI and technology (an AI strategy and roadmap was established in FY2026).
Licence to operate: sustainability, under the "Better Future" pillars of Circularity, Community and Collaboration.
Capital allocation framework (new in FY2026):
-
Invest in capacity, capability and productivity, and use third-party manufacturing where appropriate.
-
Leverage of 1.0–2.0x in the ordinary course (pre-acquisition).
50–80% dividend payout: of normalised NPAT.
The S31 targets exclude any corporate activity or further supply-chain consolidation. Management explicitly frames both as upside.
Initiatives announced or executed in the last 24 months
| Initiative | Announced | Scope | Targets / benefit | Status |
|---|---|---|---|---|
| Strathmerton closure and consolidation into Ridge Street, Bega | May 2025 | Cheese cut, wrap and processing | About A$30m a year of savings from early FY2027; FY2026 one-off cost A$12.9m | Completed June 2026 |
| Peanut processing exit (PCA) | 9 July 2025 | Sale of Kingaroy and Tolga; long-term roasted-peanut supply agreement | Savings recognised earlier than expected in 2H FY2026; loss on sale A$2.9m; about 150 employees affected (more than 80% at Kingaroy redeployed) | Completed June 2026 |
| Laverton DC automation | FY2024–FY2026 | Largest refrigerated warehouse | About A$8m annualised savings | Live 2H FY2026; fully operational July 2026 |
| Leeton juice processing sale | Completed October 2024 | Asset-light juice supply | Not quantified | Completed |
| Frenchs Forest warehouse sale | 1H FY2026 | Chilled-network consolidation | Proceeds within A$19.0m of FY2026 asset sales | Completed |
| Yoghurt capacity (Morwell) | FY2025–FY2027 | New pouch line; further capacity | Supports a category growing 16% | Ongoing |
| Protein MBB and cream cheese capacity | 1H FY2027 | Growth capex | Supports international and protein growth | Under way |
| Ridge Street processed-cheese capacity | FY2026 | International processed cheese | Supports SE Asia growth | Ongoing |
| AI strategic revenue management and RPA | FY2025–FY2026 | Pricing, trade spend, back office | Not quantified | Rolled out |
| Back-office efficiency programme | FY2026 | Overhead reduction | Benefits in FY2027 | Implementation costs in FY2026 Unallocated |
| MyBega B2B portal | Rolled out FY2025 | More than 20,000 customers | Cost to serve | Complete |
| International in-market expansion | FY2025–FY2026 | Teams in Singapore, Thailand, Dubai; in-market sourcing | International Branded +12% in FY2026 | Ongoing |
| Infant formula canning JV | 2H FY2025 | Partner not publicly identified in reviewed sources | Infant-nutrition volume | Operating |
| Better Future sustainability strategy | FY2025 | Circularity, Community, Collaboration | See Section 20 | Ongoing |
| Middle East conflict response | 4Q FY2026 | Customer surcharges; temporary farmer milk support payments | Offsets fuel and resin inflation | Ongoing into FY2027 |
Medium-term guidance
| Horizon | Guidance / target |
|---|---|
| FY2027 | Normalised EBITDA A$240–245m (+6–9%), weighted to 2H. 1H Bulk is expected to be A$5–10m lower (Quartr call summary). Capex about A$110m. About A$38m of savings from Ridge Street and Laverton. |
| FY2031 | Normalised EBITDA above A$310m; revenue A$4.3–4.7bn; EPS 37–39c; double-digit ROFE |
| Implied FY2026–31 CAGRs | Normalised EBITDA about 6.6%; EPS about 10–12% |
Products & Services
Category positions (Branded, Australia)
| Category | Category size FY2026 (AUD Mn) | Category growth FY2026 (%) | Bega share FY2026 (%) | Rank FY2026 | Share FY2025 (%) | Rank FY2025 |
|---|---|---|---|---|---|---|
| Yoghurt | 2,445 | 16 | 24 | 2 | 24 | 2 |
| Fresh white milk | 2,361 | 6 | 15 | 2 | 12 | 3 |
| Milk-based beverages | 1,355 | 14 | 43 | 1 | 46 | 1 |
| Spreads | 827 | 7 | 26 | 1 | 28 | 1 |
| Chilled juice | 767 | 4 | 17 | 2 | 18 | 2 |
| Creams & custards | 711 | 7 | 7 | 4 | 8 | 4 |
| Water ice | 63 | -5 | 92 | 1 | 89 | 1 |
Source: Circana Market Edge, 12 months to 28 June 2026, retail sales value, as reported in the FY2026 Annual Report and Results Presentation. FY2025 comparisons are from the FY2025 Results Presentation (Circana, 12 months to 29 June 2025).
Branded portfolio by brand
| Brand | Category | Description and flagship offerings | Recent innovation (year) | Target customer |
|---|---|---|---|---|
| Vegemite (power brand) | Spreads | Iconic yeast-extract spread; "Makes 'Em Mitey" campaign with sprinter Gout Gout and The Wiggles | Vegemite for kids range (FY2026) | Families; Australian expatriates and international |
| Bega Peanut Butter | Spreads | #1 peanut butter; Smooth, Crunchy and "Simply Nuts" variants | Whipped Bega Peanut Butter (FY2025); first flavoured peanut spreads, Creamy Caramel and Marshmallow Raspberry (2026) | Mainstream households |
| Bega (power brand; international) | Cheese, cream cheese, slices | Leading international cheese brand; cream cheese and cheese slices expanding in SE Asia and the Middle East. Domestic Bega-branded cheddar and butter is made and marketed by the licensee (formerly Fonterra, now Lactalis). | Expanded cream cheese and slices ranges (FY2026) | Asian and Middle East retail and foodservice |
| Dairy Farmers (power brand) | White milk, flavoured milk, smoothies, custard | Heritage dairy brand (125th anniversary 2025); "Start with OOMPH" platform; Travis Head campaign | Protein Smoothies (FY2025, national FY2026); Dairy Farmers Protein Milk with 18g protein per serve (FY2026); Mars-flavoured milk (FY2025) | Families; health-conscious consumers |
| Dare (power brand) | Iced coffee (MBB) | #1 iced coffee brand; NRL and Brad Jones Racing partnerships | Dare Protein (FY2025; #1 protein iced coffee); Dare Protein Mocha (FY2026); Dare Charged energy/low-calorie long-life range (FY2025) with new flavours (FY2026) | Young adults; tradespeople |
| Farmers Union (power brand) | Yoghurt; iced coffee (SA) | #1 yoghurt brand and top international brand; Greek Yogurt; SA iced-coffee icon | Greek Yoghurt Protein 500g (FY2025); Gut Good gut-health yoghurt (FY2025); Farmers Union Protein Yogurt range across pouches, cups and tubs (FY2026); "Protein Made Delicious" campaign | Health and wellness; protein seekers |
| Big M | Flavoured milk | Victorian flavoured-milk icon | Maltesers-flavoured Big M (FY2025) | Youth and impulse |
| Pura | White milk | Mainstream and lactose-free milk | Lactose-free white milk expanded nationally (FY2025–FY2026) | Digestive-wellness consumers |
| Masters | White and flavoured milk (WA) | WA-made milk brand | "WA made" campaigns (FY2025) | West Australian households |
| Yoplait (licensed) | Yoghurt | Licensed international yoghurt brand | Sugar reduction below Healthy Food Partnership target of 12.5g/100g (FY2026) | Mainstream families |
| Daily Juice | Chilled juice | Chilled juice and drinks | Reformulation and pack redesign (FY2025) | Households |
| Zooper Dooper | Water ice | Freeze-pops; 92% category share | — | Children and families |
| Betta Milk / Meander Valley Dairy / Pyengana (licence) | Milk, cream, butter (Tasmania) | Acquired from TasFoods (1H FY2024); perpetual royalty-free Pyengana licence for milk and cream | — | Tasmanian and premium consumers |
| Creams & custards (Dairy Farmers and others) | Creams, custards | #4 position, 7% share | — | Households |
| Foodservice range | Milk, cream, cheese, MBB | Café and QSR supply; above-market growth | Increased resources and portfolio (FY2026) | Foodservice operators |
Brand ownership is per company materials. Launch years for individual SKUs are given where disclosed in results presentations. Pricing models are not disclosed: all are retail-priced FMCG sold via wholesale price lists and trade promotion.
The broader portfolio from the Lion Dairy & Drinks and Mondelez acquisitions includes further secondary brands. A complete SKU-level list is not published in the reviewed filings.
Bulk Nutritionals and Ingredients portfolio
| Product line | Description and specifications | Sites | Customers | Notes |
|---|---|---|---|---|
| Milk protein concentrate (MPC) | Concentrated whole-milk protein retaining the natural casein:whey ratio, so it carries all nine essential amino acids; neutral taste; shelf-stable | Tatura, Koroit (recent expansion) | Bega's own high-protein brands; external beverage and nutrition manufacturers | Bega says it is Australia's largest MPC manufacturer. It benefits from record whey protein concentrate (WPC) prices driving reformulation to MPC (FY2026 Annual Report case study). |
| Lactoferrin and bio-nutrients | High-value whey-derived protein for infant and medical nutrition | Tatura | Infant-formula and nutrition makers | Yield and price realisation highlighted in FY2026 |
| Infant and nutritional formula bases | Spray-dried nutritional powders; toll manufacturing; canning JV established 2H FY2025 (partner not disclosed) | Tatura | Infant-formula brand owners | Infant-nutrition volume grew in FY2026 |
| Cream cheese (ingredient and branded) | Bega is historically Australia's largest Australian-owned cream-cheese maker (via Tatura) | Tatura | Foodservice, industrial, export | Capacity investments under way in FY2027 |
| Dairy fats (butter, AMF, cream) | Commodity fats | Koroit, Tatura, Lagoon Street | Global commodity buyers | Fat prices fell most sharply in FY2026 |
| Milk powders (SMP, WMP) and whey | Commodity powders | Koroit, Tatura, Lagoon Street (whey dryer) | Global buyers | Used for milk-flow balancing |
| Toll manufacturing | Processing third-party milk or ingredients for a fee | Various | Third parties | Supports Bulk returns (FY2026) |
Financial Narrative
Sources: FY2022–FY2026 results releases, FY2025 and FY2026 Results Presentations, and the FY2026 Annual Report (Remuneration Report five-year table). Ratios are calculated by this analyst from reported figures unless labelled "reported".
Income statement
Notes on the income statement:
-
Diluted EPS is not separately disclosed in the reviewed documents. It is immaterially different from basic, given modest performance-rights dilution.
-
FY2023 statutory EPS is not shown in reviewed sources. Arithmetically it is roughly -75c on about 304m shares; this is an analyst estimate and is not charted.
-
FY2021 comparatives: revenue A$2,073.4m; statutory EBITDA A$184.5m; normalised EBITDA A$141.7m; statutory PAT A$78.0m.
Balance sheet
Key balances only, as presented in the FY2025 and FY2026 Results Presentations.
Notes on the balance sheet:
-
The short-term versus long-term split of borrowings is not given in the reviewed presentations. Core bank debt sits under the Common Terms Deed facilities, which mature in January 2030 and January 2031.
-
Receivables and payables are distorted by Rabobank Trade Receivables Facility (TRF) timing. In FY2025, receivables fell A$154m and payables A$103m, mostly TRF timing.
-
The FY2026 working-capital increase was A$7.9m (higher inventory and payables).
Cash flow
There have been no on-market buybacks; the DRP is active and issues new shares.
Ratios
Notes on the ratios:
-
ROIC is not reported by Bega. Bega reports ROFE (EBIT divided by average funds employed, where funds employed equals net assets plus net debt), which is functionally equivalent to a pre-tax ROIC.
-
It is not shown.
-
Cash conversion cycle components are distorted by TRF usage and should be read directionally only.
-
FY2024 COGS is approximated from the normalised gross margin.
Commentary on trends, inflections and drivers
Revenue.
-
The FY2022 step-up (+45%) is the first full-year consolidation of Lion Dairy & Drinks.
-
FY2023 (+12%) was inflation-driven: farm-gate and commodity prices both spiked.
-
FY2024–FY2025 growth slowed to 4.3% and 0.5% as cheese and white-milk price deflation and weaker convenience foot traffic offset volume gains.
-
FY2026 reaccelerated to 6.7%. Branded grew 5.7% on yoghurt (category +16%), milk-based beverages and white milk. Bulk grew 12.5% on 7% more milk intake and a richer protein mix.
Profitability inflection.
-
FY2023 was the trough. Normalised EBITDA was A$160.2m and ROFE 3.7%. Bulk margins collapsed as Australian farm-gate milk prices disconnected from falling global commodity returns. The company took a A$230m after-tax impairment on bulk commodity assets.
-
The FY2024–FY2026 recovery has two distinct engines:
-
Branded self-help: site closures (Canberra, Leeton, Tasmania, Strathmerton, Kingaroy and Tolga), procurement savings, and mix shift to protein and "better for you" products. Branded normalised EBITDA rose from A$199.9m to A$220.7m despite A$8–10m a year of incremental marketing.
-
Bulk normalisation: from -A$18.2m to +A$53.2m, which exceeded the company's own A$30–50m "through-the-cycle" target range for the segment.
-
-
Normalised EPS more than doubled from 9.4c (FY2023) to 22.6c (FY2026). This reflects operating leverage on a largely fixed D&A and interest base.
Statutory versus normalised gap.
-
Normalising items have been persistent: about A$30m (FY2022), about A$16m (FY2023, excluding impairment), -A$1.0m (FY2024), A$36.5m (FY2025) and A$23.3m (FY2026) at EBITDA level.
-
Management argues these are transformation costs with clear payback; for example, Strathmerton's A$12.9m one-off cost buys about A$30m a year of savings.
-
Investors should note, however, that "one-off" restructuring has recurred in every year of the past five. Statutory ROE remains a modest 5.5%.
Cash flow.
-
FY2026 free cash flow after leases was roughly break-even (-A$0.7m). This was due to A$37.1m of restructuring cash and capex stepping up to A$109.8m (the Ridge Street cheese capacity, Morwell yoghurt and Laverton automation projects).
-
FY2027 capex is guided at about A$110m. With restructuring cash falling away and about A$38m of savings, FY2027 FCF should improve materially. This is an analyst inference.
Balance sheet.
-
Leverage fell from 2.3x (FY2021) to 0.8x (FY2025–FY2026). That is below the company's own 1.0–2.0x target band in its new capital allocation framework, signalling balance-sheet capacity for M&A or capital management.
-
Intangibles (A$464.5m) are dominated by Vegemite and the acquired dairy brands. There was no brand impairment in FY2024–FY2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Key products | Principal sites |
|---|---|---|---|
Branded | Consumer and foodservice products sold through grocery, route, foodservice, petrol and convenience, plus international branded exports | Yoghurt, fresh white milk, milk-based beverages, spreads (Vegemite, peanut butter), chilled juice, creams and custards, water ice, processed and cream cheese (international Bega brand), culinary | Morwell, Penrith, Salisbury, Smithfield, Wetherill Park, Crestmead, Malanda, Bentley, Lenah Valley, Chelsea, Port Melbourne, Ridge Street (Bega) |
Bulk Nutritionals and Ingredients | Nutritional powders, dairy ingredients and commodities sold to manufacturers; toll manufacturing; supply of dairy solids to Branded | MPC, lactoferrin, infant/nutritional bases, cream cheese (ingredient), butter and AMF, milk powders, whey products | Tatura, Koroit, Lagoon Street (Bega) |
Unallocated | Corporate overheads, SaaS, back-office programmes | — | Corporate |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Branded external revenue (AUD Mn) | 3,039.2 | 3,048.3 | 3,222.6 |
Bulk external revenue (AUD Mn) | 482.5 | 490.7 | 552.0 |
Group revenue (AUD Mn) | 3,521.6 | 3,539.0 | 3,774.6 |
Branded normalised EBITDA (AUD Mn) | 199.9 | 205.2 | 220.7 |
Bulk normalised EBITDA (AUD Mn) | -18.2 | 38.7 | 53.2 |
Unallocated overheads normalised EBITDA (AUD Mn) | -20.1 | -40.7 | -46.3 |
Inter-segment elimination (AUD Mn) | 2.5 | -1.2 | -2.0 |
Group normalised EBITDA (AUD Mn) | 164.1 | 202.0 | 225.6 |
Branded EBITDA margin on external revenue (%) | 6.6 | 6.7 | 6.8 |
Bulk EBITDA margin on external revenue (%) | -3.8 | 7.9 | 9.6 |
Branded share of group revenue (%) | 86.3 | 86.1 | 85.4 |
Bulk share of group revenue (%) | 13.7 | 13.9 | 14.6 |
Branded external revenue growth YoY (%) | — | 0.3 | 5.7 |
Bulk external revenue growth YoY (%) | — | 1.7 | 12.5 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 3,009.9 | 3,376.0 | 3,521.6 | 3,539.0 | 3,774.6 |
Revenue growth YoY (%) | 45.2 | 12.2 | 4.3 | 0.5 | 6.7 |
Gross profit statutory (AUD Mn) | — | — | — | 730.2 | 785.5 |
Gross profit normalised (AUD Mn) | — | — | — | 759.8 | 802.4 |
Gross margin normalised (%) | — | — | 19.8 | 21.5 | 21.3 |
Gross margin statutory (%) | — | — | — | 20.6 | 20.8 |
EBITDA statutory (AUD Mn) | 149.9 | 144.1 | 165.1 | 165.5 | 202.3 |
EBITDA normalised (AUD Mn) | 180.1 | 160.2 | 164.1 | 202.0 | 225.6 |
D&A normalised (AUD Mn) | — | — | 88.0 | 91.2 | 94.7 |
D&A incl. impairment, statutory (AUD Mn) | — | — | 90.8 | 138.4 | 95.4 |
EBIT (operating income) normalised (AUD Mn) | 76.4 | — | 76.1 | 110.8 | 130.9 |
EBIT statutory (AUD Mn) | — | — | 74.3 | 27.1 | 106.9 |
Net finance costs (AUD Mn) | — | — | 34.5 | 33.8 | 32.2 |
Pre-tax income normalised (AUD Mn) | 64.0 | 35.2 | 41.6 | 77.0 | 98.7 |
Pre-tax income statutory (AUD Mn) | — | — | 39.8 | -6.7 | 74.7 |
Net income normalised (AUD Mn) | 46.3 | 28.5 | 29.2 | 50.8 | 69.0 |
Net income statutory (AUD Mn) | 24.2 | -229.9 | 30.5 | -8.5 | 54.8 |
EPS basic normalised (A cents) | 15.2 | 9.4 | 9.6 | 16.6 | 22.6 |
EPS basic statutory (A cents) | 8.0 | — | 10.0 | -2.8 | 17.9 |
Dividends per share declared (A cents) | 11.0 | 7.5 | 8.0 | 12.0 | 14.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Normalised EBITDA margin (%) | 6.0 | 4.7 | 4.7 | 5.7 | 6.0 |
Statutory EBITDA margin (%) | 5.0 | 4.3 | 4.7 | 4.7 | 5.4 |
Normalised EBIT margin (%) | 2.5 | — | 2.2 | 3.1 | 3.5 |
Normalised net margin (%) | 1.5 | 0.8 | 0.8 | 1.4 | 1.8 |
Statutory net margin (%) | 0.8 | -6.8 | 0.9 | -0.2 | 1.5 |
Valuation Snapshot
| Metric | Value |
|---|---|
Revenue CAGR FY2022–FY2026 (4 years) | 5.8% |
Revenue CAGR FY2021–FY2026 (5 years, includes the Lion acquisition) | 12.7% |
Normalised EBITDA CAGR FY2023–FY2026 | 12.1% |
Normalised EPS CAGR FY2023–FY2026 | 33.9% |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | 2,138.8 | 2,040.7 | 2,157.6 |
Cash & equivalents (AUD Mn) | — | — | 65.6 | 120.9 | 133.4 |
Trade & other receivables (AUD Mn) | — | — | 350.9 | 196.8 | 239.9 |
Inventories (AUD Mn) | — | — | 358.1 | 366.3 | 437.2 |
Property, plant & equipment (AUD Mn) | — | — | 673.4 | 657.8 | 690.8 |
Right-of-use assets (AUD Mn) | — | — | 150.8 | 148.5 | 136.0 |
Goodwill & intangibles (AUD Mn) | — | — | 476.6 | 472.4 | 464.5 |
Trade & other payables (AUD Mn) | — | — | 558.4 | 455.0 | 561.1 |
Borrowings, net of costs (AUD Mn) | — | — | 226.7 | 246.0 | 283.3 |
Lease liabilities (AUD Mn) | — | — | 192.2 | 193.6 | 184.2 |
Provisions (AUD Mn) | — | — | 120.6 | 148.1 | 116.9 |
Total liabilities (AUD Mn) | — | — | 1,124.0 | 1,060.5 | 1,160.8 |
Total equity / net assets (AUD Mn) | — | — | 1,014.8 | 980.2 | 996.8 |
Net debt, excluding leases (AUD Mn) | 265.1 | 203.6 | 162.4 | 126.1 | 151.6 |
Net working capital, reported (AUD Mn) | — | 224.8 | — | — | — |
NTA per share (A cents) | 186.1 | 124.2 | 127.1 | 117.7 | 129.7 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | 158.0 | — | 134.3 | 165.0 | 129.3 |
Capex incl. intangibles (AUD Mn) | — | — | 74.6 | 94.4 | 109.8 |
Free cash flow, OCF less capex (AUD Mn) | — | — | 59.7 | 70.6 | 19.5 |
Lease principal payments (AUD Mn) | — | — | 21.4 | 24.0 | 20.2 |
FCF after lease principal (AUD Mn) | — | — | 38.3 | 46.6 | -0.7 |
Asset sale proceeds (AUD Mn) | — | — | 34.7 | 21.3 | 19.0 |
Investments in JVs & acquisitions (AUD Mn) | — | — | 12.4 | 3.2 | 4.9 |
Dividends paid, cash (AUD Mn) | — | — | 19.4 | 28.4 | 37.3 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Restructuring cash payments (AUD Mn) | — | — | — | — | 37.1 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROFE, normalised, reported (%) | — | 3.7 | 5.6 | 8.4 | 10.0 |
ROE, normalised, on average equity (%) | — | — | — | 5.1 | 7.0 |
ROE, statutory (%) | — | — | — | -0.9 | 5.5 |
ROA, normalised, on average assets (%) | — | — | — | 2.4 | 3.3 |
Leverage: net debt / normalised EBITDA, reported (x) | 1.8 | 1.6 | 1.3 | 0.8 | 0.8 |
Borrowings / equity (x) | — | — | 0.22 | 0.25 | 0.28 |
Borrowings + leases / equity (x) | — | — | 0.41 | 0.45 | 0.47 |
Interest coverage: normalised EBIT / net finance costs (x) | — | — | 2.2 | 3.3 | 4.1 |
Asset turnover: revenue / average assets (x) | — | — | — | 1.69 | 1.80 |
Inventory days on statutory COGS (days) | — | — | 46 | 48 | 53 |
Receivable days (days) | — | — | 36 | 20 | 23 |
Payable days on COGS (days) | — | — | 72 | 59 | 69 |
Cash conversion cycle, approximate (days) | — | — | 10 | 9 | 8 |
Segment Overview — Branded
| Segment | Australia (%) | International (%) | Australia (AUD Mn, derived) | International (AUD Mn, derived) |
|---|---|---|---|---|
Branded (A$3,223m) | 91 | 9 | 2,933 | 290 |
Bulk Nutritionals & Ingredients (A$552m) | 42 | 58 | 232 | 320 |
Group (A$3,775m) | 84 | 16 | 3,171 | 604 |
Revenue by Region and Region Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
International Branded revenue (AUD Mn) | 257 | 259 | 290 |
International Branded growth (%) | 11 | 1 | 12 |
Geographic Revenue
| Region | Countries named | Imports 2024 (kt) | Import CAGR 2014–24 (%) |
|---|---|---|---|
North Asia | China, Taiwan, Hong Kong | 350 | 3 |
Southeast Asia | Singapore, Malaysia, Indonesia, Philippines, Thailand | 180 | 5 |
Middle East | UAE, Saudi Arabia | 250 | 8 |
Share Price and Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Closing share price at 30 June (AUD) | 3.82 | 2.85 | 4.25 | 5.46 | 5.88 |
Enterprise value, company-reported (AUD Mn) | 1,422 | 1,070 | 1,456 | 1,791 | 1,945 |
Dividends per share (A cents) | 11.0 | 7.5 | 8.0 | 12.0 | 14.5 |
Share Price History
| Period | Price move | Notes |
|---|---|---|
1 year | About +20% | From about A$5.34 (29 October 2025) |
3 years | About +110% | From about A$3.0 in October 2023. Motley Fool notes the stock "doubled since October 2023". |
5 years | About +69% from 30 June 2022 (A$3.82) | The company's five-year TSR index chart is in the FY2026 Remuneration Report. |
Valuation Multiples
| Multiple | Bega |
|---|---|
P/E, trailing normalised (22.6c) | 28.5x |
P/E, trailing statutory (17.9c) | 36x (Morningstar shows 36.5x) |
EV/EBITDA, FY2026 normalised (EV including leases A$2.31bn; EBITDA includes the AASB 16 benefit) | 10.2x |
EV/EBITDA, FY2027 guidance midpoint (A$242.5m) | 9.5x |
EV/Sales (excluding leases) | 0.56x |
P/B (equity A$996.8m) | 2.0x |
Dividend yield (14.5c) | 2.2%, fully franked (about 3.2% grossed-up) |
Interim by Year
| Year | Interim (A cents) | Final (A cents) | Total (A cents) | Notes |
|---|---|---|---|---|
FY2021 | — | 5.0 | 10.0 | Interim not shown in reviewed sources |
FY2022 | 5.5 | 5.5 | 11.0 | — |
FY2023 | 4.5 | 3.0 | 7.5 | Interim derived as total less final |
FY2024 | 4.0 | 4.0 | 8.0 | Interim derived as total less final |
FY2025 | 6.0 | 6.0 | 12.0 | — |
FY2026 | 7.0 | 7.5 | 14.5 | Final paid 1 October 2026 |
Debt Facilities
| Facility | Limit | Lender(s) | Maturity |
|---|---|---|---|
Common Terms Deed Facility 1 | A$270m | Six-bank syndicate (Westpac agent) | January 2030 (previously July 2027) |
Common Terms Deed Facility 2 | A$180m | Six-bank syndicate | January 2031 (previously February 2027) |
Inventory Facility and Trade Receivables Facility | — | Rabobank | — |
Guarantee facilities | — | Westpac | — |
Covenant | Net debt / normalised EBITDA ≤ 3.5x at year end | — | Actual 0.8x |
“—” = not publicly disclosed.
Analyst Conclusions
Management guidance
FY2027 normalised EBITDA: A$240–245m (+6–9%), subject to normal trading conditions.
-
Growth is 2H-weighted.
-
Branded growth plus about A$38m of savings should offset a guided A$5–10m 1H Bulk decline as commodity fat prices soften.
FY2027 capex: about A$110m.
FY2031: normalised EBITDA above A$310m; revenue A$4.3–4.7bn; EPS 37–39c; double-digit ROFE.
Consensus growth expectations
Broker commentary post-Investor Day (FNArena, May 2026) emphasised management's blueprint for double-digit EPS growth through FY2031.
Bull case
-
Embedded savings plus operating leverage.
-
The about A$38m of FY2027 savings alone equals about 17% of FY2026 EBITDA.
-
Restructuring cash rolls off from A$37.1m.
-
D&A and interest are broadly fixed.
-
On these numbers, EPS could compound in the high teens, at the upper end of the S31 trajectory (22.6c to 37–39c).
-
-
Protein supercycle with dual capture. Bega earns margin as both MPC ingredient supplier and brand owner. Yoghurt is growing 16% and MBB 14%, and GLP-1 adoption is still early.
-
Optionality from balance-sheet capacity. Leverage of 0.8x (target 1.0–2.0x) gives roughly A$200–250m of debt capacity before reaching 1.5x (analyst estimate). That could fund bolt-on M&A, which S31 explicitly excludes, or accelerated international capacity.
Bear case
-
Margins remain structurally thin.
-
EBITDA margin of 6.0% and net margin of 1.8% leave little buffer.
-
Hormuz-driven inflation in fuel, resin and packaging, plus retailer resistance to surcharges, could absorb the savings.
-
-
Lactalis as a super-competitor. Lactalis now owns Mainland, Pauls, Ice Break and the Bega cheese licence. It could use its scale and procurement clout to pressure Bega in MBB (where share has already slipped from 46% to 43%), white milk and milk procurement.
-
Bulk cyclicality and "perennial one-offs".
-
Bulk swung from -A$18m to +A$53m in two years and is now guided lower in 1H FY2027.
-
Normalising items have recurred annually.
-
At about 28x normalised P/E, the stock prices in execution perfection.
-
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| October–November 2026 | 2026 AGM: trading update; reaffirmation of FY2027 guidance; vote on the remuneration report (strike risk given the pay increases) |
| Ongoing | FY2027 opening farm-gate milk price versus the commodity milk value spread |
| Ongoing | Delivery of Ridge Street (A$30m) and Laverton (about A$8m) savings |
| February 2027 | 1H FY2027 results: Bulk decline versus the A$5–10m guide; Branded margin; international growth |
| Ongoing | Middle East conflict and oil, resin and packaging costs; durability of surcharges |
| Ongoing | Corporate activity: any acquisition announcement; register changes (Tattarang; May and June 2026 substantial holders) |
| Ongoing | Circana share data in MBB, yoghurt and spreads versus Lactalis |
| Ongoing | Capacity commissioning in yoghurt, protein MBB and cream cheese |
| August 2027 | FY2027 results and the second year of the S31 trajectory |
Analyst verdict
Bega Cheese enters FY2027 in the strongest operating position of its listed life. Normalised EBITDA has grown 41% since the FY2023 trough. ROFE has nearly tripled to 10.0%, and leverage of 0.8x sits below even management's own target band. The transformation from a commodity-exposed co-operative to a brand-led staples company is now largely complete. About 85% of revenue is Branded, the footprint has been cut by successive closures, and the innovation engine is pointed at the right consumer trend: protein, gut health and convenience.
The near-term earnings path is unusually visible. Roughly A$38m of identified FY2027 savings, a disappearing restructuring cash drag and a fixed D&A and interest base support management's A$240–245m guidance. They also make the S31 ambition of about A$310m by FY2031 credible rather than heroic.
The risks are equally clear. Margins remain thin at 6% EBITDA. Lactalis's acquisition of Mainland has created a domestic super-competitor that also controls the licence to Bega's own namesake cheese. Bulk earnings remain hostage to the farm-gate-to-commodity spread, and are guided lower in 1H FY2027. The 2026 geopolitical oil and packaging shock is a live test of pricing power with concentrated retailers.
Governance also merits attention. The executive-chair model, a cash-settled chair LTI and a large CEO pay reset coincided with the best year in a decade, and investors may push back at the AGM.
At about 28x trailing normalised earnings and about 9.5x FY2027 EV/EBITDA, the market is already crediting much of the self-help story. The stock is a quality-improving, execution-dependent compounder whose upside skew depends on two things: sustained branded share gains against Lactalis, and disciplined deployment of its significant balance-sheet capacity. Neutral-to-constructive.
Key monitorables:
-
1H FY2027 Branded margin delivery
-
MBB share trajectory
-
Any M&A announcement
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure in role | Prior roles / background | Education | FY2026 total fixed remuneration (AUD) |
|---|---|---|---|---|---|
Barry Irvin AM | Executive Chairman | Chairman since 2000 per company biography (executive chair since about January 2020) | Led Bega from regional co-op to national food group; director of Tatura Milk Industries, Capitol Chilled Foods and Geoffrey Gardiner Dairy Foundation; former independent director of Warrnambool Cheese & Butter (2010–13); Chairman of Giant Steps (since 2002) and the Regional Circularity Co-operative | GAICD | 819,000 (A$559,000 executive plus A$260,000 chair) |
Peter (Pete) Findlay | Chief Executive Officer | CEO since February 2023; COO from June 2022; CFO November 2019 to October 2022 | More than 20 years in senior CFO roles across retail, IT, manufacturing and distribution | Not disclosed in reviewed sources | 1,400,000 (up 35.8% effective 1 July 2025) |
Gunther Burghardt | Chief Financial Officer | Since October 2022 | Not disclosed in reviewed sources | — | 706,000 (from A$688,000) |
Brett Kelly | Company Secretary | Since 2002 | Chartered Accountant with 41 years' experience | BCom, FCA, GAICD | Not KMP |
Jacqueline Scarlett | General Counsel | Since about January 2020 | — | — | Not KMP |
Hamish Reid | EGM Bulk Nutritionals & Ingredients | — | — | — | Not KMP |
Antonietta Timms | EGM Branded Business Operations | — | — | — | Not KMP |
Adam McNamara | EGM Growth Channels & Customer Supply Chain | — | — | — | Not KMP |
Rob Grima | EGM Operational Excellence | — | — | — | Not KMP |
David McKinnon | EGM People & Capability | Since about 2012 | — | — | Not KMP |
Darryn Wallace | EGM Retail Sales, Marketing & Partnerships | — | — | — | Not KMP |
“—” = not publicly disclosed.
Board of Directors
| Director | Role | Independent? | Appointed | Committees | Key background |
|---|---|---|---|---|---|
Barry Irvin AM | Executive Chairman | No (executive) | Board long-standing; chair since 2000 | — | See above |
Peter Margin | Deputy Chairman | Yes | September 2020 | Chair, Risk & Sustainability | Former Executive Chairman of Asahi Holdings (Australia), CEO of Goodman Fielder, CEO and COO of National Foods; Chairman of Golf Australia; director of Bundaberg Brewed Drinks; former NED of Costa, Nufarm, Endeavour |
Raelene Murphy | Director | Yes | June 2015 | Chair, Audit; member NRPCC; member Risk & Sustainability | Former MD at KordaMentha, turnaround partner, CEO of Delta Group, Mars executive; NED of Tabcorp, Integral Diagnostics, Amotiv; Chair of WiseTech Global; former NED of Altium, Elders |
Terry O'Brien | Director | Yes | September 2017 | Chair, Nomination, Remuneration, People & Capability Committee; member Audit | MD of Simplot Australia 2001–17; former Chairman of the Australian Food and Grocery Council; Chairman of Bundaberg Brewed Drinks |
Patria Mann | Director | Yes | September 2019 | Audit; Risk & Sustainability | Former KPMG partner; NED of GWA, GDI Property, Bapcor; former NED of EVT, Ridley |
Rick Cross | Director | Yes (since 23 December 2023, when he ceased supplying milk) | December 2011 | Chair, Milk Services Committee; member NRPCC | Former Tatura Milk board member; negotiated the Tatura deals; former Chair of Murray Dairy |
Harper Kilpatrick | Director | Treated as non-independent supplier director. The Annual Report says "Director since April 2021" without the "Independent" label; he and his wife own and operate dairy farms. | April 2021 | Audit; Milk Services | Dairy farmer (VIC and TAS); former Deputy CFO / Head of Finance at Almarai; ex-NED of Murray Goulburn, West Vic Dairy |
Janette Kendall | Director | Yes | 27 February 2025 | NRPCC; Risk & Sustainability (from 18 August 2025) | NED of Tabcorp, Vicinity Centres, KM Property Funds; former NED of Costa; marketing and digital executive (Australia and China) |
Board & Management Changes
| Date | Change |
|---|---|
October 2022 | Gunther Burghardt appointed CFO |
February 2023 | Pete Findlay appointed CEO, replacing Paul van Heerwaarden |
23 December 2023 | Rick Cross reclassified as independent |
27 February 2025 | Janette Kendall appointed to the board |
FY2026 | No KMP changes; remuneration reset (above) |
Competitive Landscape
Key Competitors
| Competitor | Ownership | Categories competing with Bega | Relative positioning |
|---|---|---|---|
Lactalis Australia (Parmalat; now also Mainland Group) | Private, France (Besnier family) | White milk (Pauls), flavoured milk and iced coffee (Ice Break, Oak), yoghurt (e.g. Vaalia), cheese and butter (Mainland, Western Star, Perfect Italiano; Bega-branded cheddar under licence) | Now the largest dairy player in Australia after acquiring Mainland; Bega's most formidable rival across MBB, white milk and cheese |
Saputo Dairy Australia | Saputo Inc., TSX-listed (Canada) | Bulk ingredients, cheese (Devondale, Cracker Barrel, Liddells) | Large milk processor; competes for the Victorian milk pool |
Fonterra (ingredients) | NZ co-operative | Bulk dairy ingredients globally; continues to supply milk to divested brands | Global price-setter in commodities |
a2 Milk Company | ASX/NZX-listed | Premium white milk, infant formula | Niche premium milk competitor in ANZ; infant-nutrition benchmark |
Coles and Woolworths private label (Coles owns milk processing plants acquired from Saputo) | ASX-listed retailers | Private-label milk, cheese, yoghurt | Price competition; trading-down risk |
Chobani Australia | Private (US) | Yoghurt (Greek, high-protein) | Key protein yoghurt rival |
Danone (YoPro, Activia) | Euronext-listed | High-protein and gut-health yoghurt | Direct competitor in protein and gut-health yoghurt |
Norco Co-operative | NSW farmer co-op | White milk, ice cream (NSW/QLD) | Regional milk competitor |
Sanitarium (Up&Go; peanut butter) | Private (Seventh-day Adventist Church) | Breakfast drinks (MBB adjacency), spreads | Spreads and MBB adjacency |
Bulla Dairy Foods | Private | Creams, ice cream | Creams & custards competitor (Bega #4) |
Peters Ice Cream / Unilever-origin brands (Streets, Calippo) | Private / listed | Frozen treats | Adjacent to Zooper Dooper |
Kraft Heinz / Pic's / Mayver's | Various | Peanut butter and spreads | Spreads competitors |
Global imported-cheese exporters (Fonterra, FrieslandCampina, Arla) | Various | Bega's international cream cheese and slices | Competitors in Asian import markets |
Peer Comparison FY2026
| Metric | Bega Cheese (FY2026, A$) | a2 Milk (FY2026, NZ$) |
|---|---|---|
Revenue | 3,774.6m | 1,974.9m |
Revenue growth | 6.7% | 12.4% |
EBITDA margin | 6.0% normalised | 14.4% reported; 15.6% underlying |
R&D intensity | Not disclosed (<1% inferred) | — |
Leverage (net debt/EBITDA) | 0.8x | Net cash (historically) |
“—” = not publicly disclosed.
Recent Developments
The register covers April 2025 to October 2026, with a small number of earlier items for context.
There were no material litigation, guidance downgrades, product recalls or large layoffs beyond the site closures in the period. The company reports no food-safety recalls in FY2026.



